Can Outpatient Telehealth Therapy Be as Effective as In-Person Treatment?
When telehealth exploded into everyday use during the COVID-19 pandemic, it was largely treated as a stopgap, a way to keep care going when clinic doors had to close. Five years later, the question has shifted. The question is no longer whether treatment can be delivered virtually but whether virtual care is just as effective. For individuals seeking outpatient services for a mental health condition or substance use disorder (SUD), deciding how to receive care is now an important part of the treatment process.
The short answer, based on a growing body of peer-reviewed research, is that outpatient telehealth therapy holds up remarkably well against in-person treatment for most people. But "holds up well" isn't the same as "identical," and the outpatient SUD population in particular has some nuances worth understanding before choosing a format.
What the Research Says About Telehealth vs. In-Person Therapy Generally
The clearest signal in the literature is one of clinical equivalence rather than superiority in either direction. A 2024 systematic review published in npj Digital Medicine examined 77 studies comparing telehealth to in-person care across a range of clinical areas. The review concluded that differences in outcomes and healthcare utilization were generally small and often not clinically meaningful, though it noted that outcomes varied by condition and that many studies carried some risk of bias (Hatef et al., 2024). Similarly, a systematic review and meta-analysis focused specifically on anxiety disorders found no significant differences between telehealth and face-to-face interventions in symptom reduction, functional outcomes, or depression symptoms across the trials reviewed (Krzyżaniak et al., 2024).
The therapy itself — CBT, DBT, motivational interviewing, medication management — doesn't change between formats. What changes is the medium through which it's delivered, and the research increasingly suggests that medium matters less than we once assumed.
Where the Evidence Gets More Specific: Outpatient SUD Treatment
Substance use treatment is a more complicated case than general outpatient mental health care, partly because it often combines individual counseling, group therapy, medication management, and monitoring — each of which may respond differently to a virtual format.
A 2022 review in Psychiatric Services looked specifically at this question. Drawing on eight published studies comparing telehealth-delivered addiction treatment with in-person care, the review found that seven of the eight studies showed telehealth to be equally effective in terms of retention, therapeutic alliance, and substance use outcomes (Mark et al., 2022). The one outlier actually favored telehealth: a Canadian study found that telehealth facilitated methadone prescribing and improved retention relative to in-person care (Mark et al., 2022). The review's authors were most confident that individual counseling translated well to telehealth, and less certain about group counseling and medication management, which may benefit from more hands-on oversight (Mark et al., 2022).
More recent data adds nuance rather than contradiction. A retrospective cohort study of 544 treatment-seeking SUD patients found that those who used video-based telehealth within their first 14 days of care had a lower hazard of dropout compared to patients receiving solely in-person services, while telephone-only telehealth showed no meaningful difference from in-person care (Gainer et al., 2023). That distinction is worth sitting with: video-based sessions appear to preserve more of the visual and relational cues that support engagement than audio-only calls do, which is part of why our own telehealth outpatient track leans on video rather than phone check-ins.
At a larger scale, a 2025 analysis of electronic health record data across 141 U.S. health systems found that patients treated by clinicians who made heavy use of telehealth had lower rates of SUD-related hospitalization and longer prescription supply periods for medications for substance use disorder, with no increase in adverse events compared to patients of low-telehealth clinicians (Qeadan et al., 2025). The authors framed telehealth as a "sustainable alternative" to in-person SUD care rather than a diminished one (Qeadan et al., 2025).
Intensive outpatient programming (IOP) has also held up under scrutiny. A longitudinal study of more than 1,000 patients discharged from IOP treatment (delivered in-person, hybrid, or fully virtual) found that virtual IOP care produced self-reported abstinence, health, and well-being outcomes at three-month follow-up that were comparable to in-person and hybrid formats (Gliske et al., 2022).
Why the Gains Aren't Just About Symptom Reduction
Equivalent clinical outcomes are only part of the story. Access is arguably where telehealth makes its strongest case for outpatient SUD care specifically. Transportation, childcare, work schedules, and rural geography have historically been some of the biggest practical barriers keeping people out of treatment. Telehealth removes several of those barriers outright, and the research above suggests it does so without a corresponding drop in engagement or effectiveness for most patients, a point we've explored in more depth in our previous blog post, The Role of Telehealth in Modern Addiction Recovery.
That said, telehealth isn't a universal fit. Group therapy, a core component of many outpatient SUD tracks, can feel different on a screen. Some patients report more difficulty forming connections with fellow group members and more discomfort discussing sensitive material through a webcam (Mark et al., 2022). Privacy at home, unreliable internet access, and a lack of a private space to speak candidly can also undercut the format for certain patients, which is one reason hybrid models are gaining traction rather than an all-or-nothing shift to virtual care.
What This Means If You're Choosing Between Formats
None of this research suggests telehealth is a compromise. It points instead to the idea that the right format is the one that matches the person, not a fixed hierarchy where in-person is inherently "more real" treatment. For individual counseling, medication management check-ins, and many CBT- or DBT-based interventions, video-based telehealth appears to perform on par with sitting across from a clinician in an office.
For people balancing work, caregiving, or geographic distance from a treatment center, that equivalence matters enormously, because it means the more accessible option isn't also the lesser one. Sometimes the biggest determinant of whether someone gets care at all is whether the format feels approachable enough to start. On that measure, the evidence is fairly encouraging: telehealth seems to help more people walk through the (virtual) door, without asking them to sacrifice the quality of care once they're inside it.
Telehealth at Recovery Hub
At Recovery Hub, we built our telehealth outpatient track with these same distinctions in mind rather than simply moving in-person sessions onto a screen. Individual counseling and medication management — the two areas the research most consistently supports as translating well to a virtual format — are delivered live, over video, with the same licensed clinicians who see clients in person. For group sessions, we've leaned into smaller group sizes and structured facilitation to help offset the connection challenges that can come with meeting on camera rather than in a room.
We also don't ask clients to choose one format and stick with it forever. Many people move between telehealth, in-person, and hybrid participation as their schedules, transportation, and comfort level change over the course of treatment. If you're weighing whether telehealth is the right fit for your own outpatient care, our team can walk through your specific situation and help you decide what combination of virtual and in-person support makes sense for you.
References
Gainer, D. M., Wong, C., Embree, J. A., Sardesh, N., Amin, A., & Lester, N. (2023). Effects of telehealth on dropout and retention in care among treatment-seeking individuals with substance use disorder: A retrospective cohort study. Substance Use & Misuse, 58(4), 481–490. https://doi.org/10.1080/10826084.2023.2167496
Gliske, K., Welsh, J. W., Braughton, J. E., Waller, L. A., & Ngo, Q. M. (2022). Telehealth services for substance use disorders during the COVID-19 pandemic: Longitudinal assessment of intensive outpatient programming and data collection practices. JMIR Mental Health, 9(3), Article e36263. https://doi.org/10.2196/36263
Hatef, E., Wilson, R. F., Zhang, A., Hannum, S. M., Kharrazi, H., Davis, S. A., Foroughmand, I., Weiner, J. P., & Robinson, K. A. (2024). Effectiveness of telehealth versus in-person care during the COVID-19 pandemic: A systematic review. npj Digital Medicine, 7, Article 152. https://doi.org/10.1038/s41746-024-01152-2
Krzyżaniak, N., Greenwood, H., Scott, A. M., Peiris, R., Cardona, M., Clark, J., & Glasziou, P. (2024). The effectiveness of telehealth versus face-to-face interventions for anxiety disorders: A systematic review and meta-analysis. Journal of Telemedicine and Telecare, 30(2), 250–261. https://doi.org/10.1177/1357633X211053738
Mark, T. L., Treiman, K., Padwa, H., Henretty, K., Tzeng, J., & Gilbert, M. (2022). Addiction treatment and telehealth: Review of efficacy and provider insights during the COVID-19 pandemic. Psychiatric Services, 73(5), 484–491. https://doi.org/10.1176/appi.ps.202100088
Qeadan, F., Shimizu, S., Tingey, B., Kroth, P. J., & Markossian, T. (2025). The impact of increased telehealth use on the treatment of substance use disorder during the COVID-19 pandemic. SSM - Population Health, 30, Article 101780. https://doi.org/10.1016/j.ssmph.2025.101780
